Antigenicity of bovine papillomavirus type 1 (BPV-1) L1 virus-like particles compared with that of intact BPV-1 virions

Journal of General Virology

Volumn 77, Issue 2, 1996, Pages 183-188

  Ghim, Shin Je ^a   Young, Rachel ^a   Jenson, A Bennett ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRION; VIRUS MORPHOLOGY; VIRUS PARTICLE;

ANIMALIA; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; CERVIDAE; EUKARYOTA; PAPILLOMAVIRUS;

EID: 0030044745     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-2-183     Document Type: Article

References (30)

1. BAKER. C. C. (1987). Sequence analysis of papillomavirus genomes. In The Papovaviridae, vol. 2, pp. 321-385. Edited by N. P. Salzman & P. M. Howley. New York: Plenum Press.
2. BAKER, T. S., NEWCOMB, W. W , OLSON, H. H., COWSERT, L. M., OLSON, C. & BROWN, J. C. (1991). Structure of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three dimensional image reconstruction. Biophysical Journal 60, 1445-1460.
3. BREITBURD, F., KIRNBAUER, R., HUBBERT, N L , NONNENMACHER, B., TRIN-DINH-DESMARQUET, C., ORTH, G , SCHILLER, J T. & LOWY, D R. (1995) Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection Journal of Virology 69, 3959-3963
4. CHRISTENSEN, N. D. & KREIDER, J. W. (1990). Antibody-mediated neutralization in vivo of infectious papillomaviruses. Journal of Virology 64, 3151-3156.
5. CHRISTENSEN, N. D., KREIDER, J. W., CLADEL, N. M , PATRICK, S. D. & WELSH, P. A. (1990). Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. Journal of Virology 64, 5678-5681.
6. CHRISTENSEN, N. D., HÖPFL, R., DIANGELO, S. L., CLADEL, N. M., PATRICK, S. D., WELSH, P. A., BUDGEON, L. R., REED, C. A. & KREIDER, J. W. (1994). Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. Journal of General Virology 75, 2271-2276.
7. COWSERT, L. M., LAKE, P. & JENSON, A. B. (1987). Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. Journal of the National Cancer Institute 79, 1053-1057.
8. CRAWFORD, L. V. & CRAWFORD, E. M. (1963). A comparative study of polyoma and papilloma viruses. Virology 21, 258-263.
9. DE VILLIERS, E.-M. (1989). Heterogeneity of the human papillomavirus group. Journal of Virology 63, 4898-4903.
10. FINCH, J. I. & KLUG, A. (1965). The structure of viruses of the papilloma-polyoma type III. Structure of rabbit papilloma virus. Journal of Molecular Biology 13, 1-12
11. GHIM, S. & JENSON, A. B. (1993). Identification of conformational epitopes of the BPV-1 capsid recognized by competitive inhibition of sera from infected or immunized animals. Pathobiology 61, 138-144.
12. GHIM, S., CHRISTENSEN, N. D., KREIDER, J. W. & JENSON, A. B. (1991). Comparison of neutralization of BPV1 infection of C127 cells and bovine fetal skin xenografts. International Journal of Cancer 49, 285-289.
13. GHIM, S., SCHLEGEL, R., HINES, J. F., CHRISTENSEN, N. D., KREIDER, J. & JENSON, A. B. (1994). Comparison of PV conformational epitopes expressed by L1 proteins in mammalian (cos) and insect (Sf9) cells. In Immunology of Human Papillomaviruses, pp. 147-153. Edited by M. A. Stanley. New York: Plenum Press.
14. GHIM, S-J., SUZICH, J., TAMURA, J., BELL, J. A., WHITE, W., NEWSOME, J., HILL, F., WARRENER, P., SUNDBERG, J., JENSON, A. B. & SCHLEGEL, R. (1995). Formalin-inactivated oral papilloma extracts and recombinant L1 vaccines protect completely against mucosal papillomavirus infection: a canine model. Vaccines 95, 375-379.
15. GORRA, J. B , LANCASTER, W. D., KURMAN, R. J. & JENSON, A. B. (1985). Bovine papillomavirus type 1 monoclonal antibodies. Journal of the National Cancer Institute 75, 121-125.
16. HAGENSEE, M. E., YAEGASHI, N & GALLOWAY, D. A. (1993) Self-assembly of human papillomavirus type 1 capsid by expression of L1 protein alone or by coexpression of the L1 and L2 capsid proteins. Journal of Virology 67, 315-322.
17. HAGENSEE, M. E., OLSON, N. H., BAKER, T. S. & GALLOWAY, D. A. (1994). Three-dimensional structure of vaccinia virus produced human papillomavirus type 1 capsids. Journal of Virology 68, 4503-4505.
18. JARRETT, W. F., O'NEILL, B. W., GAUKROGER, J. M., SMITH, K. T , LAIRD, H. M. & CAMPO, M. S. (1990). Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Veterinary Record 126, 473-475.
19. JIN, X. W., COWSERT, L. M., PILACINSKI, W. P. & JENSON, A. B. (1989). Identification of L2 open reading frame gene products of bovine papillomavirus type-1 by monoclonal antibodies. Journal of General Virology 70, 1133-1140.
20. KIRNBAUER, R., BOOY, F., CHENG, N., LOWY, D. R. & SCHILLER, J T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences, USA 89, 12180-12184.
21. LAMBERT, P. F. & HOWLEY, P. M. (1988). Bovine papiliomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation. Journal of Virology 62, 4009-4015.
22. LANCASTER, W. D. & OLSON, C. (1978). Demonstration of two distinct classes of bovine papillomavirus. Virology 89, 372-379.
23. LIM, P. S., JENSON, A. B., COWSERT, L., NAKAI, Y., LIM, L. Y., JIN, X. W. & SUNDBERG, J. P. (1990). Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides Journal of Infectious Diseases 162, 1263-1269.
24. NAKAI, Y., LANCASTER, W. D., LIM, L. Y. & JENSON, A. B. (1986). Monoclonal antibodies to genus- and type-specific papillomavirus structural antigens. Intervirology 25, 30-37.
25. PFEISTER, H. (1984). Biology and biochemistry of papillomaviruses. Reviews of Physiology, Biochemistry and Pharmacology 99, 111-181.
26. PFEISTER, H. (1987). Papillomaviruses: general descriptions, taxonomy and classification. In The Papovaviridae, vol. 2, pp. 1-38. Edited by N. P. Salzman & P. M. Howley. New York: Plenum Press.
27. ROSE, R. C., REICHMAN, R. C. & BONNEZ, W. (1994). Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV specific antibodies in human sera. Journal of General Virology 75, 2075-2079
28. YAEGASHI, N., JENISON, S A , VALENTINE, J. M., DUNN, M., TAICHMAN, L. B., BAKER, D. A. & GALLOWAY, D. A. (1991). Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions. Journal of Virology 65, 1578-1583.
29. VISCIDI, R. P. & SHAH, K. V. (1992). Immune response to genital infections In Sexually Transmitted Diseases, pp. 239-260. Edited by T. C. Quinn. New York: Raven Press.
30. ZHOU, J., STENZEL, D. J., SUN, X. Y. & FRAZER, I. H. (1993). Synthesis and assembly of infectious bovine papillomavirus particles in vitro Virology 74, 763-768.